Accelerate Diagnostics Income Statement - Quarterly (NASDAQ:AXDX)

Add to My Stocks
$23.1 $0.45 (1.91%) AXDX stock closing price Mar 29, 2017 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Accelerate Diagnostics stock price. In the income statement, an investor can look at important parameters like revenue, gross profits, net profits, and EPS basic to gain deeper insights. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from $0.02M to $0.04M and how operating and non operating activities have impacted the AXDX stock. 2016-Q4 revenue is $0.04M and has increased from $0.02M quarter on quarter as is evident when you compare the latest figures in the latest Accelerate Diagnostics profit and loss statement with those of the prior corresponding period. (See also:Accelerate Diagnostics assets and Accelerate Diagnostics free cash flow) View details of revenue and profits for Accelerate Diagnostics for latest & last 40 quarters.

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3
Accelerate Diagnostics Net Sales or Revenues
Cost Of Goods Sold (COGS)----------
Accelerate Diagnostics Gross Profit
Research & Development Expense5.25M7.53M8.06M7.35M6.04M6.49M7.12M6.37M5.99M5.94M
Selling General & Admin Expense10.22M9.3M9.23M7.43M5.94M4.33M4.75M2.86M2.59M2.62M
Income Before Depreciation Depletion Amortization-15.43M-16.81M-17.28M-14.62M-11.93M-10.73M-11.86M-9.23M-8.49M-8.55M
Depreciation Depletion Amortization0.6M0.6M0.6M0.54M0.61M0.46M0.4M0.32M0.32M0.26M
Non Operating Income0.18M0.11M0.02M0.09M0.03M0.02M0.01M0.01M0.03M0.01M
Interest Expense0.02M---0.02M---0.01M-
Accelerate Diagnostics Pretax Income
Provision for Income Taxes0.26M---0.64M---0.64M--
Minority Interest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-16.14M-17.3M-17.87M-15.07M-13.16M-11.82M-12.25M-8.9M-8.77M-8.81M
Extraordinary Items & Discontinued Operations----------
Accelerate Diagnostics Net Income (Profit/Loss)
Average Shares used to compute Diluted EPS52.05M51.24M51.21M51.2M45M44.73M44.68M44.65M43.83M44.58M
Average Shares used to compute Basic EPS52.05M51.24M51.21M51.2M45M44.73M44.68M44.65M43.83M44.58M
Income Before Nonrecurring Items-16.14M-17.3M-17.87M-15.07M-13.16M-11.82M-12.25M-8.9M-8.77M-8.81M
Income from Nonrecurring Items----------
Accelerate Diagnostics Earnings Per Share Basic Net
Accelerate Diagnostics Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items-0.31-0.34-0.35-0.29-0.29-0.25-0.27-0.20-0.20-0.20
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

Accelerate Diagnostics stock analysis involves checking at least a few of the important things like:
  • Topline: A growing topline, as seen from the Accelerate Diagnostics revenue chart, as is the case with Accelerate Diagnostics indicates a growing business. One needs to compare the QoQ or YoY topline growth of AXDX stock with its peers like GKOS stock and BABY stock to see if the growth compares well with what can be expected for a company in that industry.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-16.14M for Accelerate Diagnostics for 2016-Q4. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.
The income statement is also called statement of revenue and expense. The financials along with Accelerate Diagnostics historical stock prices provides a lot of details about the firm. .

Accelerate Diagnostics Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
Operating margin
Net profit margin
Dividend yield